Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/19/2025

Differentiating Multiple System Atrophy from Progressive Supranuclear Palsy

Clinical Features

  • The American College of Radiology suggests that vertical supranuclear gaze palsy, early severe falls, and axial-predominant rigidity are characteristic of Progressive Supranuclear Palsy (PSP), whereas prominent early autonomic dysfunction, cerebellar ataxia, and preserved eye movements are characteristic of Multiple System Atrophy (MSA) 1, 2
  • PSP typically presents with a mean age of 63 years, while MSA presents between 55-65 years of age 1, 2
  • Axial-predominant rigidity affects axial muscles more than limbs in PSP, distinguishing it from MSA 3
  • Prominent early autonomic dysfunction, including urinary incontinence and orthostatic hypotension, is significantly more common in MSA than PSP 1, 2
  • Cerebellar ataxia is a characteristic feature of MSA, particularly in the MSA-C subtype, but also occurs in MSA-P 1, 2
  • Pyramidal signs are frequently reported in MSA but not characteristic of PSP 1, 2
  • The disease progression rate is approximately 6 years in MSA, with both conditions progressing more rapidly than idiopathic Parkinson's disease 1, 2

Pathophysiological Distinction

  • PSP is a tauopathy with abnormal tau protein accumulation, while MSA is a synucleinopathy with alpha-synuclein accumulation in oligodendroglia 1, 2, 4

Clinical Algorithm for Differentiation

  • Assessing eye movements, with vertical supranuclear gaze palsy suggesting PSP and preserved vertical gaze with square-wave jerks suggesting MSA 1, 2, 3
  • Evaluating fall history, with severe falls within the first year suggesting PSP 1, 2
  • Assessing autonomic function, with early severe urinary incontinence and orthostatic hypotension suggesting MSA 1, 2
  • Checking for cerebellar signs, with prominent ataxia and dysmetria suggesting MSA 1, 2

REFERENCES

3

Diagnosis and Treatment of Parkinson's Disease [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

4

Histologic Findings in Parkinson's Disease [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025